Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 30% ± 8% |
Insufficient scRNA-seq data for expression of TYSND1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2211.20 | 245 / 245 | 100% | 29.76 | 502 / 502 |
uterus | 100% | 1517.06 | 170 / 170 | 100% | 24.45 | 458 / 459 |
ovary | 100% | 1426.08 | 180 / 180 | 100% | 21.07 | 429 / 430 |
breast | 100% | 1876.68 | 459 / 459 | 100% | 26.27 | 1115 / 1118 |
pancreas | 100% | 1056.82 | 327 / 328 | 100% | 18.26 | 178 / 178 |
thymus | 100% | 2057.36 | 653 / 653 | 100% | 21.46 | 603 / 605 |
kidney | 100% | 1535.26 | 89 / 89 | 100% | 16.56 | 897 / 901 |
skin | 100% | 2724.33 | 1809 / 1809 | 99% | 21.21 | 469 / 472 |
bladder | 100% | 1597.33 | 21 / 21 | 99% | 29.12 | 500 / 504 |
esophagus | 100% | 1747.33 | 1440 / 1445 | 99% | 19.65 | 182 / 183 |
stomach | 99% | 1079.16 | 357 / 359 | 100% | 21.05 | 285 / 286 |
intestine | 100% | 1501.38 | 966 / 966 | 98% | 25.37 | 519 / 527 |
adrenal gland | 100% | 1882.98 | 257 / 258 | 98% | 14.90 | 225 / 230 |
liver | 99% | 1090.60 | 223 / 226 | 99% | 18.06 | 400 / 406 |
brain | 95% | 884.63 | 2504 / 2642 | 100% | 13.56 | 704 / 705 |
lung | 95% | 1066.70 | 549 / 578 | 99% | 23.87 | 1148 / 1155 |
eye | 0% | 0 | 0 / 0 | 100% | 40.93 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 31.64 | 29 / 29 |
spleen | 100% | 2175.40 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.89 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 34.56 | 1 / 1 |
adipose | 100% | 1680.94 | 1200 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 921.90 | 1316 / 1335 | 0% | 0 | 0 / 0 |
heart | 90% | 574.69 | 776 / 861 | 0% | 0 | 0 / 0 |
muscle | 84% | 438.67 | 676 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 84% | 955.20 | 782 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031998 | Biological process | regulation of fatty acid beta-oxidation |
GO_0016485 | Biological process | protein processing |
GO_0006508 | Biological process | proteolysis |
GO_0005829 | Cellular component | cytosol |
GO_0005777 | Cellular component | peroxisome |
GO_0005782 | Cellular component | peroxisomal matrix |
GO_0016020 | Cellular component | membrane |
GO_0002020 | Molecular function | protease binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | TYSND1 |
Protein name | Peroxisomal leader peptide-processing protease (EC 3.4.21.-) (Trypsin domain-containing protein 1) [Cleaved into: Peroxisomal leader peptide-processing protease, 15 kDa form; Peroxisomal leader peptide-processing protease, 45 kDa form] |
Synonyms | |
Description | FUNCTION: Peroxisomal protease that mediates both the removal of the leader peptide from proteins containing a PTS2 target sequence and processes several PTS1-containing proteins. Catalyzes the processing of PTS1-proteins involved in the peroxisomal beta-oxidation of fatty acids. . |
Accessions | ENST00000287078.7 [Q2T9J0-1] ENST00000335494.5 [Q2T9J0-2] Q2T9J0 |